
Developing a combination product is more complex than developing a drug or a medical device independently. When a drug, device, or biological component is brought together into a single therapeutic solution, the development team must consider not only the performance of each constituent part, but also how the components work together throughout the product lifecycle.
A successful combination product therefore requires more than a good product concept. It requires early regulatory planning, cross-functional collaboration, risk management, controlled development activities, appropriate testing, manufacturing readiness, and continued monitoring after the product reaches the market.
So, what does the complete development lifecycle look like? Although individual development programs may differ depending on the type of product and applicable regulatory pathway, the process can be understood through a series of connected stages.
1. Define the Combination Product and Its Intended Purpose
The first step is to clearly establish what the product is intended to achieve.
A combination product may bring together a drug and device, a biological product and device, or other regulated constituent parts. Examples include prefilled syringes, autoinjectors, drug-delivery systems, drug-eluting devices, and other products where the components are intended to work together. At this stage, the organization should establish:
- What is the intended use of the product?
- Who is the intended user?
- What medical condition is being addressed?
- How will the product be used?
- What role does each constituent part perform?
- What therapeutic or clinical outcome is expected?
This definition becomes the foundation for subsequent design, risk management, testing, and regulatory activities.
For example, an autoinjector cannot be evaluated only as a mechanical device. Its ability to deliver the intended medicinal product in the required manner is part of the overall product purpose.
The question is therefore not simply whether the device works.
Does the complete product work as intended?
2. Establish the Regulatory Strategy Early
Regulatory planning should begin at the early stages of development rather than after the product has already been designed.
Combination products can involve different regulatory frameworks because their constituent parts may traditionally be regulated as different types of products. The applicable pathway can depend on the nature of the product and, in some regulatory systems, the primary mode of action or other classification considerations.
A regulatory strategy should therefore establish:
- Product classification: How is the combination product categorized?
- Regulatory pathway: Which regulatory route is applicable?
- Regulatory authority: Which authority or authorities will have responsibility?
- Evidence requirements: What information will be required to demonstrate safety, quality, and effectiveness?
- Submission strategy: What documentation and supporting evidence will be required?
Early interaction with regulatory authorities can be particularly valuable where the classification or development pathway is complex.
Why wait until the submission stage to discover that an important development activity was not adequately planned?
Early regulatory engagement can reduce uncertainty and help align product development with the eventual regulatory expectations.
3. Develop the Product Strategy
Once the product concept and regulatory direction are understood, the organization should establish a structured development plan. A combination product development plan should identify the major activities, responsibilities, resources, milestones, and decision points required to move the product from concept toward commercialization.
The plan may include:
- product and user requirements;
- development activities;
- regulatory milestones;
- risk-management activities;
- prototype development;
- testing;
- human factors activities;
- manufacturing development;
- validation;
- regulatory submission; and
- commercialization activities.
The development team should also have access to the necessary expertise.
Combination products often require collaboration between pharmaceutical scientists, engineers, quality professionals, regulatory specialists, manufacturing personnel, human-factors specialists, clinicians, and other subject-matter experts.
A development plan that considers only one constituent part can create problems later when the drug and device need to be integrated.
4. Establish User Needs and Design Requirements
The development process should translate the intended use and user needs into clear and measurable requirements. For example, if a combination product is intended for self-administration at home, the development team may need to consider ease of use, dose delivery, handling, storage conditions, user instructions, and foreseeable use errors.
The requirements should provide a clear basis for development and subsequent verification and validation. For a drug-delivery device, this could include requirements relating to:
- dose delivery;
- delivery time;
- mechanical performance;
- materials;
- packaging;
- usability;
- environmental conditions;
- reliability; and
- compatibility with the medicinal product.
The requirements should not be developed independently for the drug and device where their performance is interconnected. The important consideration is the performance of the complete combination product.
5. Integrate Risk Management and Quality Assurance
Risk management should be integrated throughout development rather than treated as a separate activity performed at the end. The organization should identify hazards associated with the constituent parts as well as risks that arise from their interaction.
Examples may include:
- incorrect dose delivery;
- device malfunction;
- drug-device incompatibility;
- material interaction;
- usability errors;
- packaging failure;
- transportation-related damage;
- contamination; and
- changes in product performance during the lifecycle.
Tools such as Failure Mode and Effects Analysis (FMEA) can help identify and prioritize potential failure modes and support the development of appropriate controls. At the same time, the quality system should establish controlled processes for development activities, documentation, review, testing, manufacturing, changes, and other applicable processes. Regular reviews and audits can help determine whether development activities remain aligned with the established requirements. Quality assurance is therefore not simply a final inspection activity.
It is a control mechanism that supports product quality throughout development.
6. Develop, Verify and Validate the Product
Once requirements and risks have been established, the product can progress through detailed development and testing. This stage can include prototype development, engineering builds, laboratory testing, usability studies, performance testing, and other activities required to demonstrate that the product meets its defined requirements. For a combination product, testing may need to evaluate both the individual constituent parts and their interaction.
For example, a delivery device may meet its mechanical requirements when tested independently. However, when used with the intended drug formulation, its performance may be affected by viscosity, materials compatibility, storage conditions, or other characteristics of the medicinal product. Verification activities should therefore demonstrate that specified requirements have been met, while validation should establish that the resulting product can meet its intended use under actual or simulated conditions of use. Human factors and usability activities can also be important where user interaction has an effect on safe and effective product use.
7. Prepare for Manufacturing and Design Transfer
A successful development program must eventually move from development activities into controlled manufacturing.
Design transfer is the stage where the outputs of development are translated into information that can be consistently used for production.
This may involve:
- manufacturing specifications;
- drawings and specifications;
- assembly instructions;
- test methods;
- acceptance criteria;
- production equipment;
- process requirements;
- supplier controls; and
- manufacturing documentation.
For combination products, manufacturing can involve multiple organizations. For example, one organization may manufacture the drug constituent while another manufactures the device, with the final product being assembled or packaged elsewhere. Responsibilities therefore need to be clearly defined across the supply chain. Engineering builds and production builds should also be appropriately controlled so that differences between development and routine manufacturing are understood and addressed.
8. Validate the Manufacturing Process
Once the manufacturing process has been established, the organization needs to demonstrate that it can consistently produce the intended product. Process validation activities may include qualification and validation of equipment, manufacturing processes, assembly processes, test methods, and other applicable operations.
For combination products, particular attention may be required where manufacturing conditions can influence the interaction between the drug and device. For example, an assembly process may affect the integrity of a delivery system, while a packaging process may influence product protection or stability. Manufacturing validation should therefore consider not only whether the process produces a device that meets specification, but whether it consistently produces the complete combination product that meets its intended requirements.
9. Prepare for Regulatory Submission and Commercialization
After development, verification, validation, and manufacturing activities have generated the required evidence, the organization can prepare the regulatory submission and commercialization strategy.
The supporting documentation should provide a clear and traceable demonstration of how the product was developed and controlled.
Depending on the product and regulatory pathway, this may include information related to:
- product design;
- constituent parts;
- risk management;
- verification and validation;
- human factors;
- manufacturing;
- process controls;
- quality systems;
- clinical or performance evidence; and
- applicable regulatory requirements.
A well-structured development history is particularly valuable at this stage because it allows the organization to demonstrate how decisions were made and how the final product satisfies its requirements.
10. Continue Monitoring After Market Introduction
The development lifecycle does not end when the product is commercially launched.
Combination products should continue to be monitored throughout their post-market life so that emerging issues can be identified and addressed.
This can include monitoring:
- complaints;
- adverse events;
- product performance;
- manufacturing issues;
- supplier issues;
- customer feedback;
- field performance; and
- regulatory developments.
Why is this important?
A product that performs acceptably during development may encounter different conditions when used by a much larger and more diverse population.
Post-market information can therefore identify opportunities for corrective action, product improvement, risk reassessment, or future design changes.
Bringing the Lifecycle Together
The combination-product lifecycle can be viewed as a connected sequence:
Concept → Regulatory Strategy → Development Planning → User Needs & Design → Risk Management → Verification & Validation → Design Transfer → Manufacturing Validation → Regulatory Submission → Commercialization → Lifecycle Monitoring
These stages should not be treated as isolated activities.
A change made during development can affect risk management. A change in formulation can affect device performance. A manufacturing change can affect product quality. A complaint after commercialization can reveal a previously unidentified use-related risk.
This is why effective combination-product development requires continuous communication between functions.
Partner with TS Quality & Engineering for Your Combination Product
Combination product development requires organizations to manage several disciplines at the same time. The product must satisfy its intended therapeutic purpose while the drug, device, and other constituent parts perform together safely and consistently.
The four fundamental principles are straightforward:
- Understand the product: Clearly define the constituent parts, intended use, users, and therapeutic purpose.
- Plan the development: Establish the regulatory strategy, development roadmap, responsibilities, resources, and milestones early.
- Control the development: Integrate design, risk management, quality assurance, verification, validation, manufacturing, and regulatory activities.
- Manage the lifecycle: Continue monitoring the product and controlling changes after commercialization.
The organizations that approach combination-product development as an integrated lifecycle, rather than as separate drug and device projects, are better positioned to identify problems early, maintain regulatory compliance, control development risks, and bring reliable products to patients.
Ultimately, the objective is not simply to develop a drug and a device that each meet their individual requirements. The objective is to develop a complete product that consistently delivers the intended benefit safely and effectively throughout its lifecycle.
Navigating the complex, cross-functional requirements of combination product development—from regulatory classification and risk management (ISO 14971) to human factors, design transfer, and post-market surveillance—requires specialized expertise.
At TS Quality & Engineering, we provide end-to-end quality assurance, regulatory compliance, and engineering consulting tailored to your product’s full lifecycle. Whether you need assistance structuring your regulatory submission strategy, conducting usability studies, or establishing robust quality management systems, our team is equipped to accelerate your path to market while mitigating technical and regulatory risks.
Ready to streamline your development process?
Visit our Contact Us Page today to request a tailored consultation and proposal for your combination product strategy.




















